Business Wire - Tuesday May 18, 1999
Their invaluable contribution to HIV vaccine research is helping bring us closer to our goal: developing a safe and effective vaccine to prevent HIV, a virus that infects an estimated 16,000 people a day worldwide.
On May 18, 1997, President Clinton issued a challenge to the world to develop a safe and effective vaccine to prevent HIV by the year 2007 -- projecting it as one of the first and most significant medical advances of the new millennium. These comments inspired the declaration of an annual event designed to recognize the compelling need for the advancement of HIV vaccine research.
"We at VaxGen are proud to honor our clinical trials volunteers who are lending their bodies to science in order to help develop an HIV vaccine," said Donald Francis, M.D., President of VaxGen. "As a volunteer, myself, in one of our own trials, I recognize the critical role volunteers play in vaccine research and I would like to recognize the contribution made by this small group of pioneers."
VaxGen is currently conducting two large-scale Phase III clinical trials of its AIDSVAX vaccines, one in North America and one in Thailand. The North American trial will eventually include over 5,000 volunteers at risk of contracting HIV through sexual transmission and is currently being conducted at 58 clinics. The Thai trial will eventually include 2,500 volunteers at high-risk of contracting HIV from intravenous drug use. The trial is being conducted at 17 drug treatment clinics in Bangkok.
People interested in volunteering for the trial may call toll free (877) 6-VAXGEN for further information.
VaxGen, Inc., headquartered in Brisbane, CA, is developing preventive vaccines for worldwide use against HIV.
Additional information is available on our web site at: www.vaxgen.com
Contact: VaxGen, Inc. Nicole Lynch, 650/624-1065
990518
BW990506
Copyright © 1999 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .